AHA GUIDELINES Bundle (free trial)

High Blood Pressure - Merck Supported

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1539869

Contents of this Issue

Navigation

Page 81 of 87

82 Complications of Management Table 26. Intravenous Antihypertensive Drugs for Treatment of Hypertensive Emergencies Class Drug(s) Usual Dose Range Adrenergic blockers Combined alpha-1 and nonselective beta receptor antagonist Labetalol Initial 0.3–1.0-mg/kg dose (maximum 20 mg ) slow IV injection every 2 min or 0.4–1.0-mg/kg/h IV infusion up to 3 mg/kg/h. Adjust rate up to total cumulative dose of 300 mg/24 hours. Adrenergic blockers Nonselective alpha receptor antagonist Phentolamine IV bolus dose 5 mg. Additional bolus doses every 10 min as needed to lower BP to target. Adjust rate up to total cumulative dose of 50 mg/24 h. Dopamine-1 Receptor selective agonist Fenoldopam Initial 0.1–0.3 mcg/kg/min; may be increased in increments of 0.05–0.1 mcg/kg/min every 15 min until target BP is reached. Maximum infusion rate 1.6 mcg/kg/min. ACE inhibitor Enalaprilat Initial 1.25 mg over a 5-min period. Doses can be increased up to 5 mg every 6 h as needed to achieve BP target. Adjust rate up to total cumulative dose of 50 mg/24 h. MI, myocardial infarction. Modified with permission from Whelton et al. Copyright © 2018 American College of Cardiolog y Foundation and American Heart Association, Inc. (cont'd)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - High Blood Pressure - Merck Supported